These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2282250)

  • 1. Growth factors and oncogenes in prostate cancer.
    Thompson TC
    Cancer Cells; 1990 Nov; 2(11):345-54. PubMed ID: 2282250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic research in prostate cancer: molecular biology.
    Effert PJ; Strohmeyer TG
    Acta Urol Belg; 1994 Apr; 62(1):15-21. PubMed ID: 8197925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental oncogene induced prostate cancer.
    Thompson TC; Kadmon D; Timme TL; Merz VW; Egawa S; Krebs T; Scardino PT; Park SH
    Cancer Surv; 1991; 11():55-71. PubMed ID: 1726789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene expression in prostate cancer.
    Schalken JA; Bussemakers MJ; Debruyne FM
    Prog Clin Biol Res; 1990; 357():97-105. PubMed ID: 2217484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of prostatic growth and function by peptide growth factors.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
    Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?
    Suh J; Rabson AB
    J Cell Biochem; 2004 Jan; 91(1):100-17. PubMed ID: 14689584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
    Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M
    Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biologic aspects of human prostatic carcinoma.
    Netto GJ; Humphrey PA
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S57-64. PubMed ID: 7942612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers associated with prostate cancer progression.
    Zhau HE; Pisters LL; Hall MC; Zhao LS; Troncoso P; Pollack A; Chung LW
    J Cell Biochem Suppl; 1994; 19():208-16. PubMed ID: 7529853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytologic molecular detection of oncogene expression: possibilities and prospects in hemato-oncology].
    Greil R; Fasching B; Huber H
    Acta Med Austriaca; 1990; 17(1):6-10. PubMed ID: 2191534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.